Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.
AffiliationCRC Department of Med. Oncology, Christie Hospital (NHS) Trust, Manchester, UK.
MetadataShow full item record
AbstractTumours develop through the accumulation of genetic alterations associated with a progressive increase of the malignant phenotype. In lung cancer, chronic exposure of bronchial epithelium to carcinogens in cigarette smoke may lead to multiple dysplastic and hyperplastic lesions scattered throughout the tracheobronchial tree. Little is known about the genetic alterations in such lesions. This study was carried out to examine cyclin D1 (CCND1) and retinoblastoma (RB1) gene expression in the bronchial epithelium of patients with lung cancer. Lung tumours and their corresponding tumour-free resection margins from 33 patients who underwent resection of non-small-cell lung cancer (NSCLC) were examined by immunostaining with monoclonal antibodies against cyclin D1 (DCS-6; Novocastra) and pRb (NCL Rb-1; Novocastra). Examination of the resection margins revealed four carcinomas in situ, 19 hyperplasias and ten sections showing apparently normal bronchial epithelium. A control group of patients, without lung tumours and who had never smoked, revealed no or weak cyclin D1 and positive pRb staining within bronchial epithelia. Increased cyclin D1 and diminished pRb expression were found in 76% (n = 25) and 27% (n = 9) of the resection margins respectively, and in 12% (n = 4) both cyclin D1 and pRb expression were altered. In the corresponding tumours, 48% (n = 16) were normal, while altered expression was found for cyclin D1 in 33% (n = 11), pRb in 27% (n = 9) and both in 9% (n = 3) of cases. It appears that altered expression of cyclin D1 and pRb is an early event in NSCLC development in almost half of cases analysed. Further investigations are needed to determine the significance of immunostaining of bronchial specimens in individuals at risk of lung cancer, with the possibility that the observations are of importance in the early diagnosis of NSCLC.
CitationAbnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. 1997, 75 (12):1761-8 Br. J. Cancer
JournalBritish Journal of Cancer
- G1 control gene status is frequently altered in resectable non-small cell lung cancer.
- Authors: Betticher DC, White GR, Vonlanthen S, Liu X, Kappeler A, Altermatt HJ, Thatcher N, Heighway J
- Issue date: 1997 Oct 21
- Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
- Authors: Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A
- Issue date: 1996 May
- p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
- Authors: Vonlanthen S, Heighway J, Kappeler A, Altermatt HJ, Borner MM, Betticher DC
- Issue date: 2000 May
- The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer.
- Authors: Kwa HB, Michalides RJ, Dijkman JH, Mooi WJ
- Issue date: 1996 Jun
- Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II.
- Authors: Jin M, Inoue S, Umemura T, Moriya J, Arakawa M, Nagashima K, Kato H
- Issue date: 2001 Nov